Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,310 JPY | +0.70% | +0.52% | -8.23% |
Apr. 30 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
Apr. 29 | US Equity Markets Close Higher Monday Ahead of Earnings, Fed Meeting This Week | MT |
Business Summary
Number of employees: 3,761
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 361,361 | 100.0 % | 447,187 | 100.0 % | +23.75% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
64.4
%
| 241,971 | 67.0 % | 288,155 | 64.4 % | +19.09% |
Americas
31.9
%
| 105,890 | 29.3 % | 142,791 | 31.9 % | +34.85% |
Asia
2.6
%
| 8,895 | 2.5 % | 11,625 | 2.6 % | +30.69% |
Europe
1.0
%
| 4,605 | 1.3 % | 4,616 | 1.0 % | +0.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 65 | 83-03-31 |
Toichi Takino
PSD | President | 55 | - |
Director/Board Member | 64 | 85-03-31 | |
Isao Ono
BRD | Director/Board Member | 65 | 81-03-31 |
Kiyoaki Idemitsu
BRD | Director/Board Member | 60 | 21-05-31 |
Kei Sano
BRD | Director/Board Member | 64 | 83-03-31 |
Director/Board Member | 59 | - | |
Moriki Ishizaki
IRC | Investor Relations Contact | - | - |
Shinji Takai
PRN | Corporate Officer/Principal | - | - |
Katsunori Morio
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Isao Ono
BRD | Director/Board Member | 65 | 81-03-31 |
Shusaku Nagae
BRD | Director/Board Member | 74 | - |
Director/Board Member | 64 | 85-03-31 | |
Shinji Fujiyoshi
AUD | Comptroller/Controller/Auditor | 67 | 80-03-31 |
Shozo Matsuoka
PRN | Corporate Officer/Principal | 64 | 85-03-31 |
Kei Sano
BRD | Director/Board Member | 64 | 83-03-31 |
Masao Nomura
BRD | Director/Board Member | 74 | 18-06-25 |
Hiroshi Ichikawa
SAM | Sales & Marketing | 62 | 84-03-31 |
Toichi Takino
PSD | President | 55 | - |
Kiyoaki Idemitsu
BRD | Director/Board Member | 60 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 498,692,800 | 378,500,747 ( 75.90 %) | 29,045,346 ( 5.824 %) | 75.90 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
28,980,082 | 5.81% | 469,996,362 $ | |
DAIKIN INDUSTRIES, LTD. 0.29% | 850,500 | 0.29% | 115,763,979 $ |
2,951,997 | 0.96% | 81,921,341 $ | |
6,204,000 | 1.70% | 62,984,869 $ | |
T&D HOLDINGS INC. 0.62% | 3,386,010 | 0.62% | 58,113,311 $ |
1,348,400 | 0.97% | 51,006,574 $ | |
KIKKOMAN CORPORATION 0.37% | 3,585,000 | 0.37% | 46,640,886 $ |
YAKULT HONSHA CO.,LTD. 0.47% | 1,614,800 | 0.47% | 33,278,670 $ |
725,200 | 0.62% | 30,192,505 $ | |
SHIMADZU CORPORATION 0.31% | 919,000 | 0.31% | 25,685,489 $ |
Company contact information
Ono Pharmaceutical Co., Ltd.
1-8-2 Kyutaromachi Chuo-Ku
541-8564, Osaka
+81 6 6263 5670
http://www.ono.co.jpSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.37% | 6.91B | |
+19.62% | 43.27B | |
+24.62% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B | |
+9.14% | 4.9B |
- Stock Market
- Equities
- 4528 Stock
- Company Ono Pharmaceutical Co., Ltd.